{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:37:20Z","timestamp":1792190240987,"version":"4.4.0"},"reference-count":63,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2020,1,24]],"date-time":"2020-01-24T00:00:00Z","timestamp":1579824000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Widespread vaccination programmes led to the global eradication of smallpox, which was certified by the World Health Organisation (WHO), and, since 1978, there has been no case of smallpox anywhere in the world. However, the viable variola virus (VARV), the causative agent of smallpox, is still kept in two maximum security laboratories in Russia and the USA. Despite the eradication of the disease smallpox, clandestine stocks of VARV may exist. In a rapidly changing world, the impact of an intentional VARV release in the human population would nowadays result in a public health emergency of global concern: vaccination programmes were abolished, the percentage of immunosuppressed individuals in the human population is higher, and an increased intercontinental air travel allows for the rapid viral spread of diseases around the world. The WHO has authorised the temporary retention of VARV to enable essential research for public health benefit to take place. This work aims to develop diagnostic tests, antiviral drugs, and safer vaccines. Advances in synthetic biology have made it possible to produce infectious poxvirus particles from chemicals in vitro so that it is now possible to reconstruct VARV. The status of smallpox in the post-eradication era is reviewed.<\/jats:p>","DOI":"10.3390\/v12020138","type":"journal-article","created":{"date-parts":[[2020,1,24]],"date-time":"2020-01-24T11:01:00Z","timestamp":1579863660000},"page":"138","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":154,"title":["Smallpox in the Post-Eradication Era"],"prefix":"10.3390","volume":"12","author":[{"given":"Hermann","family":"Meyer","sequence":"first","affiliation":[{"name":"Bundeswehr Institute of Microbiology, 80937 Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosina","family":"Ehmann","sequence":"additional","affiliation":[{"name":"Bundeswehr Institute of Microbiology, 80937 Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey L.","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Cambridge, Cambridge CB2 1QP, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,1,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1001\/jama.281.22.2127","article-title":"Smallpox as a biological weapon: Medical and public health management. Working Group on Civilian Biodefense","volume":"281","author":"Henderson","year":"1999","journal-title":"JAMA"},{"key":"ref_2","first-page":"669","article-title":"An airborne outbreak of smallpox in a German hospital and its significance with respect to other recent outbreaks in Europe","volume":"43","author":"Wehrle","year":"1970","journal-title":"Bull. World Health Organ."},{"key":"ref_3","unstructured":"Murray, P.R., Baron, E.J., Jorgensen, J.H., Pfaller, M.A., and Yolker, M.H. (2003). Poxviruses that infect humans, Manual of Clinical Microbiology."},{"key":"ref_4","unstructured":"(2020, January 24). Evaluating Patients for Smallpox: Acute, Generalized Vesicular or Pustular Rash Illness Protocol, Available online: https:\/\/www.cdc.gov\/smallpox\/clinicians\/algorithm-protocol.html."},{"key":"ref_5","unstructured":"(2020, January 24). Smallpox, Available online: https:\/\/www.cdc.gov\/smallpox\/."},{"key":"ref_6","unstructured":"Camac, C.N.B. (1959). An Inquiry into the Causes and Effects of the Variolae Vaccinae; a Disease Discovered in some of the Western Counties of England, Particularly Gloucestershire, and Known by the Name of The Cow Pox, London. Classics of Medicine and Surgery, Dover."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"7222","DOI":"10.1016\/j.vaccine.2017.11.003","article-title":"Equination (inoculation of horsepox): An early alternative to vaccination (inoculation of cowpox) and the potential role of horsepox virus in the origin of the smallpox","volume":"35","author":"Esparza","year":"2017","journal-title":"Vaccine"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1056\/NEJMc1707600","article-title":"An Early American Smallpox Vaccine Based on Horsepox","volume":"377","author":"Schrick","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_9","unstructured":"Fenner, F., Hendersan, D.A., Arita, I., Jezek, Z., and Ladnyi, I.D. (1988). Smallpox and its eradication. History of international public health, World Health Organization. no. 6."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1128\/JCM.42.5.1940-1946.2004","article-title":"Real-time PCR system for detection of orthopoxviruses and simultaneous identification of smallpox virus","volume":"42","author":"Olson","year":"2004","journal-title":"J. Clin. Microbiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1128\/JCM.42.3.1207-1213.2004","article-title":"Detection of orthopoxvirus DNA by real-time PCR and identification of variola virus DNA by melting analysis","volume":"42","author":"Nitsche","year":"2004","journal-title":"J. Clin. Microbiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jviromet.2005.05.020","article-title":"Rapid, differential diagnosis of orthopox- and herpesviruses based upon real-time PCR product melting temperature and restriction enzyme analysis of amplicons","volume":"129","author":"Carletti","year":"2005","journal-title":"J. Virol. Methods"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jviromet.2011.05.002","article-title":"Species-specific identification of variola, monkeypox, cowpox, and vaccinia viruses by multiplex real-time PCR assay","volume":"175","author":"Shchelkunov","year":"2011","journal-title":"J. Virol. Methods"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jviromet.2008.07.018","article-title":"Dual-probe real-time PCR assay for detection of variola or other orthopoxviruses with dried reagents","volume":"153","author":"Aitichou","year":"2008","journal-title":"J. Virol. Methods"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1600-065X.2010.00975.x","article-title":"Smallpox vaccines: Targets of protective immunity","volume":"239","author":"Moss","year":"2011","journal-title":"Immunol. Rev."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Kretzschmar, M., Wallinga, J., Teunis, P., Xing, S., and Mikolajczyk, R. (2006). Frequency of adverse events after vaccination with different vaccinia strains. PLoS Med., 3.","DOI":"10.1371\/journal.pmed.0030429"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1056\/NEJM196911272812201","article-title":"Complications of Smallpox Vaccination, 1968","volume":"281","author":"Lane","year":"1969","journal-title":"N. Engl. J. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/aje\/kwh269","article-title":"Myopericarditis following smallpox vaccination","volume":"160","author":"Arness","year":"2004","journal-title":"Am. J. Epidemiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"920","DOI":"10.3201\/eid0706.010602","article-title":"Developing new smallpox vaccines","volume":"7","author":"Rosenthal","year":"2001","journal-title":"Emerging Infect. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1743-422X-3-88","article-title":"Genomic sequence and analysis of a vaccinia virus isolate from a patient with a smallpox vaccine-related complication","volume":"3","author":"Li","year":"2006","journal-title":"Virol. J."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.vaccine.2008.11.063","article-title":"Phenotypic and genetic diversity of the traditional Lister smallpox vaccine","volume":"27","author":"Garcel","year":"2009","journal-title":"Vaccine"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/j.vaccine.2008.11.079","article-title":"Comparison of the safety and immunogenicity of ACAM1000, ACAM2000 and Dryvax in healthy vaccinia-naive adults","volume":"27","author":"Frey","year":"2009","journal-title":"Vaccine"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/BF01641272","article-title":"Abstammung, Eigenschaften und Verwendung des attenuierten Vaccinia-Stammes MVA","volume":"3","author":"Mayr","year":"1975","journal-title":"Infection"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"10847","DOI":"10.1073\/pnas.89.22.10847","article-title":"Nonreplicating vaccinia vector efficiently expresses recombinant genes","volume":"89","author":"Sutter","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0147-9571(03)00025-0","article-title":"Smallpox vaccination and bioterrorism with pox viruses","volume":"26","author":"Mayr","year":"2003","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.1016\/S0264-410X(01)00075-5","article-title":"Safety of modified vaccinia virus Ankara (MVA) in immune-suppressed macaques","volume":"19","author":"Stittelaar","year":"2001","journal-title":"Vaccine"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1086\/595565","article-title":"Postexposure immunization with modified vaccinia virus Ankara or conventional Lister vaccine provides solid protection in a murine model of human smallpox","volume":"199","author":"Paran","year":"2009","journal-title":"J. Infect. Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"10889","DOI":"10.1073\/pnas.0804985105","article-title":"Rapid protection in a monkeypox model by a single injection of a replication-deficient vaccinia virus","volume":"105","author":"Earl","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1172\/JCI33940","article-title":"Survival of lethal poxvirus infection in mice depends on TLR9, and therapeutic vaccination provides protection","volume":"118","author":"Samuelsson","year":"2008","journal-title":"J. Clin. Investig."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1056\/NEJMoa1817307","article-title":"Phase 3 Efficacy Trial of Modified Vaccinia Ankara as a Vaccine against Smallpox","volume":"381","author":"Pittman","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_31","unstructured":"Quinnan, G.V. (1985). Properties of attenuated mutant of vaccinia virus, LC16m8, derived from Lister strain. Vaccinia Virus as Vectors for Vaccine Antigens, Elsevier Science Publishing Co Inc."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"7009","DOI":"10.1016\/j.vaccine.2006.03.087","article-title":"LC16m8: An attenuated smallpox vaccine","volume":"24","author":"Kenner","year":"2006","journal-title":"Vaccine"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"4152","DOI":"10.1073\/pnas.0406671102","article-title":"Genetically stable and fully effective smallpox vaccine strain constructed from highly attenuated vaccinia LC16m8","volume":"102","author":"Kidokoro","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/0042-6822(91)90480-Y","article-title":"Regulation of plaque size and host range by a vaccinia virus gene related to complement system proteins","volume":"181","author":"Funahashi","year":"1991","journal-title":"Virology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1099\/0022-1317-83-12-2915","article-title":"The formation and function of extracellular enveloped vaccinia virus","volume":"83","author":"Smith","year":"2002","journal-title":"J. Gen. Virol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1099\/vir.0.034207-0","article-title":"Serological responses in humans to the smallpox vaccine LC16m8","volume":"92","author":"Johnson","year":"2011","journal-title":"J. Gen. Virol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0166-3542(02)00196-1","article-title":"Potential antiviral therapeutics for smallpox, monkeypox and other orthopoxvirus infections","volume":"57","author":"Baker","year":"2003","journal-title":"Antiviral Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1128\/AAC.46.4.991-995.2002","article-title":"Enhanced inhibition of orthopoxvirus replication in vitro by alkoxyalkyl esters of cidofovir and cyclic cidofovir","volume":"46","author":"Kern","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1128\/AAC.01489-05","article-title":"Activities of Alkoxyalkyl Esters of Cidofovir (CDV), Cyclic CDV, and (S)-9-(3-Hydroxy-2-Phosphonylmethoxypropyl)Adenine against Orthopoxviruses in Cell Monolayers and in Organotypic Cultures","volume":"50","author":"Lebeau","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1128\/AAC.00021-09","article-title":"Nonhuman primates are protected from smallpox virus or monkeypox virus challenges by the antiviral drug ST-246","volume":"53","author":"Huggins","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"13139","DOI":"10.1128\/JVI.79.20.13139-13149.2005","article-title":"An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus Challenge","volume":"79","author":"Yang","year":"2005","journal-title":"J. Virol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.vaccine.2007.11.095","article-title":"Immune responses to the smallpox vaccine given in combination with ST-246, a small-molecule inhibitor of poxvirus dissemination","volume":"26","author":"Grosenbach","year":"2008","journal-title":"Vaccine"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1056\/NEJMoa1705688","article-title":"Oral Tecovirimat for the Treatment of Smallpox","volume":"379","author":"Grosenbach","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1128\/AAC.04289-14","article-title":"Enhanced efficacy of cidofovir combined with vaccinia immune globulin in treating progressive cutaneous vaccinia virus infections in immunosuppressed hairless mice","volume":"59","author":"Smee","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/jac\/dku545","article-title":"ST-246 is a key antiviral to inhibit the viral F13L phospholipase, one of the essential proteins for orthopoxvirus wrapping","volume":"70","author":"Duraffour","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1126\/science.1125134","article-title":"Genome sequence diversity and clues to the evolution of variola (smallpox) virus","volume":"313","author":"Esposito","year":"2006","journal-title":"Science"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"15787","DOI":"10.1073\/pnas.0609268104","article-title":"On the origin of smallpox: Correlating variola phylogenics with historical smallpox records","volume":"104","author":"Li","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1134\/S1022795408080036","article-title":"Molecular evolution of poxviruses","volume":"44","author":"Babkin","year":"2008","journal-title":"Russ. J. Genet."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1016\/j.cub.2016.10.061","article-title":"17th Century Variola Virus Reveals the Recent History of Smallpox","volume":"26","author":"Duggan","year":"2016","journal-title":"Curr. Biol."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Pajer, P., Dresler, J., Kab\u00edckova, H., P\u00edsa, L., Aganov, P., Fucik, K., Elleder, D., Hron, T., Kuzelka, V., and Velem\u00ednsky, P. (2017). Characterization of Two Historic Smallpox Specimens from a Czech Museum. Viruses, 9.","DOI":"10.3390\/v9080200"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1126\/science.1072266","article-title":"Chemical synthesis of poliovirus cDNA: Generation of infectious virus in the absence of natural template","volume":"297","author":"Cello","year":"2002","journal-title":"Science"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1126\/science.1119392","article-title":"Characterization of the reconstructed 1918 Spanish influenza pandemic virus","volume":"310","author":"Tumpey","year":"2005","journal-title":"Science"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"12415","DOI":"10.1073\/pnas.192420599","article-title":"Cloning the vaccinia virus genome as a bacterial artificial chromosome in Escherichia coli and recovery of infectious virus in mammalian cells","volume":"99","author":"Domi","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"7281","DOI":"10.1128\/JVI.77.13.7281-7290.2003","article-title":"High-frequency genetic recombination and reactivation of orthopoxviruses from DNA fragments transfected into leporipoxvirus-infected cells","volume":"77","author":"Yao","year":"2003","journal-title":"J. Virol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e0188453","DOI":"10.1371\/journal.pone.0188453","article-title":"Construction of an infectious horsepox virus vaccine from chemically synthesized DNA fragments","volume":"13","author":"Noyce","year":"2018","journal-title":"PLoS ONE"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1128\/JVI.75.3.1205-1210.2001","article-title":"Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox","volume":"75","author":"Jackson","year":"2001","journal-title":"J. Virol."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Sidell, F.R., Takafuji, E.T., and Franz, D.R. (1997). Historical overview of biological warfare. Medical Aspects of Chemical and Biological Warfare, Office of the Surgeon General, Borden Institute, Walter Reed Army Medical Center.","DOI":"10.21236\/ADA398241"},{"key":"ref_58","unstructured":"Henderson, D.A. (2009). Smallpox\u2014the Death of a Disease, Prometheus Books."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1093\/cid\/cit703","article-title":"Human Monkeypox","volume":"58","author":"McCollum","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Vaughan, A., Aarons, E., Astbury, J., Balasegaram, S., Beadsworth, M., Beck, C.R., Chand, M., O\u2019Connor, C., Dunning, J., and Ghebrehewet, S. (2018). Two cases of monkeypox imported to the United Kingdom, September 2018. Eurosurveillance, 23.","DOI":"10.2807\/1560-7917.ES.2018.23.38.1800509"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"980","DOI":"10.3201\/eid2505.190076","article-title":"Diagnosis of Imported Monkeypox, Israel, 2018","volume":"25","author":"Erez","year":"2019","journal-title":"Emerg. Infect. Dis."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Gao, J., Gigante, C., Khmaladze, E., Liu, P., Tang, S., Wilkins, K., Zhao, K., Davidson, W., Nakazawa, Y., and Maghlakelidze, G. (2018). Genome Sequences of Akhmeta Virus, an Early Divergent Old World Orthopoxvirus. Viruses, 10.","DOI":"10.3390\/v10050252"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Gigante, C.M., Gao, J., Tang, S., McCollum, A.M., Wilkins, K., Reynolds, M.G., Davidson, W., McLaughlin, J., Olson, V.A., and Li, Y. (2019). Genome of Alaskapox Virus, a Novel Orthopoxvirus Isolated from Alaska. Viruses, 11.","DOI":"10.3390\/v11080708"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/12\/2\/138\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T14:08:31Z","timestamp":1760364511000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/12\/2\/138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,24]]},"references-count":63,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,2]]}},"alternative-id":["v12020138"],"URL":"https:\/\/doi.org\/10.3390\/v12020138","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,24]]}}}